Logo image of IBG

INNOVATION BEVERAGE GROUP LT (IBG) Stock Fundamental Analysis

NASDAQ:IBG - Nasdaq - AU0000226177 - Common Stock - Currency: USD

0.6565  +0.02 (+2.42%)

After market: 0.6303 -0.03 (-3.99%)

Fundamental Rating

2

Taking everything into account, IBG scores 2 out of 10 in our fundamental rating. IBG was compared to 32 industry peers in the Beverages industry. IBG may be in some trouble as it scores bad on both profitability and health. IBG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IBG had negative earnings in the past year.
In the past year IBG had a positive cash flow from operations.
IBG Yearly Net Income VS EBIT VS OCF VS FCFIBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -1M -2M -3M -4M

1.2 Ratios

IBG's Return On Assets of -45.43% is on the low side compared to the rest of the industry. IBG is outperformed by 81.25% of its industry peers.
IBG has a Return On Equity of -915.45%. This is in the lower half of the industry: IBG underperforms 78.13% of its industry peers.
Industry RankSector Rank
ROA -45.43%
ROE -915.45%
ROIC N/A
ROA(3y)-43.53%
ROA(5y)N/A
ROE(3y)-558.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBG Yearly ROA, ROE, ROICIBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

Looking at the Gross Margin, with a value of 65.26%, IBG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for IBG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBG Yearly Profit, Operating, Gross MarginsIBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

IBG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IBG remains at a similar level compared to 1 year ago.
IBG has a better debt/assets ratio than last year.
IBG Yearly Shares OutstandingIBG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
IBG Yearly Total Debt VS Total AssetsIBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

IBG has an Altman-Z score of -1.85. This is a bad value and indicates that IBG is not financially healthy and even has some risk of bankruptcy.
IBG has a Altman-Z score of -1.85. This is in the lower half of the industry: IBG underperforms 68.75% of its industry peers.
The Debt to FCF ratio of IBG is 51.41, which is on the high side as it means it would take IBG, 51.41 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 51.41, IBG is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
IBG has a Debt/Equity ratio of 1.60. This is a high value indicating a heavy dependency on external financing.
IBG's Debt to Equity ratio of 1.60 is on the low side compared to the rest of the industry. IBG is outperformed by 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 51.41
Altman-Z -1.85
ROIC/WACCN/A
WACC8.51%
IBG Yearly LT Debt VS Equity VS FCFIBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M -2M

2.3 Liquidity

A Current Ratio of 0.81 indicates that IBG may have some problems paying its short term obligations.
With a Current ratio value of 0.81, IBG is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.50 indicates that IBG may have some problems paying its short term obligations.
IBG has a worse Quick ratio (0.50) than 71.88% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.5
IBG Yearly Current Assets VS Current LiabilitesIBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.23% over the past year.
The Revenue for IBG has decreased by -30.52% in the past year. This is quite bad
EPS 1Y (TTM)51.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.23%
Revenue 1Y (TTM)-30.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-30.52%

3.2 Future

Based on estimates for the next years, IBG will show a very strong growth in Earnings Per Share. The EPS will grow by 20.48% on average per year.
Based on estimates for the next years, IBG will show a very strong growth in Revenue. The Revenue will grow by 24.40% on average per year.
EPS Next YN/A
EPS Next 2Y9.34%
EPS Next 3Y20.48%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y20.16%
Revenue Next 3Y24.4%
Revenue Next 5YN/A

3.3 Evolution

IBG Yearly Revenue VS EstimatesIBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2025 2026 2M 4M 6M
IBG Yearly EPS VS EstimatesIBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.05 -0.1 -0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IBG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IBG Price Earnings VS Forward Price EarningsIBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, IBG is valued a bit more expensive than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 191.44
EV/EBITDA N/A
IBG Per share dataIBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as IBG's earnings are expected to grow with 20.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.34%
EPS Next 3Y20.48%

More info and screens

0

5. Dividend

5.1 Amount

IBG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVATION BEVERAGE GROUP LT

NASDAQ:IBG (4/17/2025, 8:00:02 PM)

After market: 0.6303 -0.03 (-3.99%)

0.6565

+0.02 (+2.42%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.9%
Inst Owner ChangeN/A
Ins Owners23.39%
Ins Owner ChangeN/A
Market Cap5.48M
Analysts80
Price Target4.08 (521.48%)
Short Float %1.56%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.74
P/FCF 191.44
P/OCF 181.9
P/B 24.89
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.52%
OCF(TTM)0
OCFY0.55%
SpS0.38
BVpS0.03
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.43%
ROE -915.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.26%
FCFM 0.91%
ROA(3y)-43.53%
ROA(5y)N/A
ROE(3y)-558.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 51.41
Debt/EBITDA N/A
Cap/Depr 0.63%
Cap/Sales 0.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.5
Altman-Z -1.85
F-Score5
WACC8.51%
ROIC/WACCN/A
Cap/Depr(3y)114.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.23%
EPS Next YN/A
EPS Next 2Y9.34%
EPS Next 3Y20.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-30.52%
Revenue Next YearN/A
Revenue Next 2Y20.16%
Revenue Next 3Y24.4%
Revenue Next 5YN/A
EBIT growth 1Y35.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y25.29%
EBIT Next 5YN/A
FCF growth 1Y100.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.05%
OCF growth 3YN/A
OCF growth 5YN/A